Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

NCT04684212 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of Funding

Conditions

Atrial Fibrillation
Left Atrial Appendage Thrombosis
CVA

Interventions

DEVICE: LAmbre PlusTM Left Atrial Appendage Closure System
DRUG: Market approved oral anticoagulation (OAC), such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixiban (Eliquis), edoxaban (Savaysa), or betrixaban (Bevyxxa)

Sponsor

Brian O'Neill MD

Collaborators

[object Object]